A new study has found that while weight-loss drugs like Ozempic and Wegovy significantly improve health, they are also linked to a sustained increase in spending on other medical care. The study, led by Yale economics professor Jason Abaluck and published in JAMA Network Open, confirms that semaglutide (the active ingredient in Wegovy and Ozempic) effectively reduces weight, blood pressure,…